for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

Straumann Holding AG

STMN.S

Latest Trade

801.80CHF

Change

-8.80(-1.09%)

Volume

50,929

Today's Range

799.00

 - 

815.80

52 Week Range

587.00

 - 

896.20

As of on the SIX Swiss Exchange ∙ Minimum 15 minute delay

Pricing

Previous Close
810.60
Open
815.80
Volume
50,929
3M AVG Volume
1.19
Today's High
815.80
Today's Low
799.00
52 Week High
896.20
52 Week Low
587.00
Shares Out (MIL)
15.83
Market Cap (MIL)
12,871.50
Forward P/E
37.44
Dividend (Yield %)
0.59

Next Event

Q3 2019 Straumann Holding AG Corporate Sales Release

Latest Developments

More

Straumann Makes Appointments To Executive Management

Straumann Raises Guidance For FY Organic Revenue Growth

Straumann Holding Partners With Korea's Yuhan Corporation

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

About Straumann Holding AG

Straumann Holding AG is a Switzerland-based company active in the field of implant and restorative dentistry and oral tissue regeneration. In collaboration with clinics, research institutes and universities, the Group researches and develops implants, instruments, computer-aided design/manufacturing (CAD/CAM) prosthetics and tissue regeneration products for use in tooth replacement and restoration solutions or to prevent tooth loss. Straumann Holding AG also offers a range of services to the dental profession worldwide, including training and education, provided in collaboration with the International Team for Implantology (ITI). Its products and services are available in a number of countries through the Group’s headquarters and through a network of subsidiaries and technology partners located in Europe, North America, the Asia/Pacific region and in Latin America, including Dental Wings Inc based in Canada and Createch Medical SL based in Spain.

Industry

Medical Equipment & Supplies

Contact Info

Peter Merian-Weg 12

+41.61.9651111

https://www.straumann.com/

Executive Leadership

Gilbert Achermann

Non-Executive Chairman of the Board

Marco Gadola

Chief Executive Officer, Member of the Executive Management Board

Thomas Straumann

Non-Executive Vice Chairman of the Board of Directors

Peter Hackel

Chief Financial Officer, Member of the Executive Management Board

Gerhard Bauer

Member of the Executive Management Board, Head Research, Development & Operations

Key Stats

2.25 mean rating - 16 analysts
Sell
Hold
Buy
Revenue (MM, CHF)

2016

0.9K

2017

1.1K

2018

1.4K

2019(E)

1.6K
EPS (CHF)

2016

11.940

2017

15.300

2018

16.940

2019(E)

21.651
Price To Earnings (TTM)
44.55
Price To Sales (TTM)
8.80
Price To Book (MRQ)
10.32
Price To Cash Flow (TTM)
35.44
Total Debt To Equity (MRQ)
39.72
LT Debt To Equity (MRQ)
19.68
Return on Investment (TTM)
18.46
Return on Equity (TTM)
14.79

Latest News

BRIEF-Straumann Makes Appointments To Executive Management

* STRAUMANN GROUP ANNOUNCES TWO APPOINTMENTS TO ITS EXECUTIVE MANAGEMENT TEAM

BRIEF-Straumann Will Not Explore Collaboration With Align Technology

* STRAUMANN DECIDES NOT TO EXPLORE INTRAORAL SCANNER COLLABORATION WITH ALIGN TECHNOLOGY Source text for Eikon: Further company coverage: (Gdynia Newsroom)

BRIEF-Straumann Says Q1 Organic Revenue Growth Of 17%

* Q1 GROUP REVENUE CLIMBS 15% IN SWISS FRANCS TO CHF 372 MILLION

BRIEF-Straumann Group: 2019 AGM Approves All Proposals

* 2019 AGM APPROVES ALL PROPOSALS Source text for Eikon: Further company coverage: (Gdynia Newsroom)

BRIEF-Straumann Holding Raises Stake In French Implant Manufacturer Anthogyr To 100%

* STRAUMANN GROUP INCREASES STAKE IN FRENCH IMPLANT MANUFACTURER ANTHOGYR FROM 30% TO 100%.

BRIEF-Straumann Holding To Enter Clear Aligner Market In China

* EXCLUSIVE DISTRIBUTION AGREEMENT FOR CLEAR ALIGNERS DEVELOPED AND REGISTERED IN CHINA BY TIANJIN ZHENGLI TECHNOLOGY CO Source text for Eikon: Further company coverage: (Reporting by Isabela Prinz)

UPDATE 1-Straumann says CEO Gadola to step down in 2020

Straumann Holding Chief Executive Marco Gadola will step down at the start of next year, the dental implant maker said on Tuesday, as the current head of its North American business is groomed to replace him.

Straumann says CEO Gadola to step down in 2020

Straumann Holding said Marco Gadola will step down as its chief executive at the start of next year, the dental implant maker said on Tuesday, and be replaced by the current head of its North American business.

BRIEF-Straumann Group And Nobel Biocare Settle Patent Dispute

* NOBEL BIOCARE HAS NOW AGREED TO TAKE NO FURTHER ACTION REGARDING DECISION AND TO DISMISS ITS PENDING COURT ACTION

BRIEF-Straumann Enters Strategic Partnership With Z-Systems

* COMPANIES HAVE SIGNED AN AGREEMENT THAT PROVIDES STRAUMANN WITH A 34% STAKE IN Z-SYSTEMS

Dental implant maker Straumann ups full year guidance

Dental implant maker Straumann Holding raised its full year sales outlook on Tuesday, saying new products and its wider market presence would mean faster growth this year.

BRIEF-Straumann To Gain Control Of Taiwan's T-Plus

* GROUP TO GAIN CONTROL OF T-PLUS, AN ESTABLISHED TAIWANESE MANUFACTURER OF ATTRACTIVELY-PRICED IMPLANT SYSTEMS

BRIEF-Straumann: Peter Zihla Joins Executive Management Team As New Head Of Digital Business Unit

* PETER ZIHLA JOINS STRAUMANN'S EXECUTIVE MANAGEMENT TEAM AS NEW HEAD OF DIGITAL BUSINESS UNIT Source text for Eikon: Further company coverage: (Gdynia Newsroom)

BRIEF-Straumann H1 EBITDA Increased 29% To CHF 203 Mln

* FIRST-HALF REVENUE SURGES 25% IN SWISS FRANCS (18% ORGANIC) TO CHF 682 MILLION

BRIEF-Straumann Holding Acquires 30% Stake In Botiss

* ACQUIRED A 30% STAKE IN ITS BIOMATERIALS PARTNER BOTISS MEDICAL AG FOR AN UNDISCLOSED SUM Source text for Eikon: Further company coverage: (Gdynia Newsroom)

BRIEF-Straumann And Zirkonzahn USA Sign Cooperation Agreement For US, Canada

* STRAUMANN GROUP AND ZIRKONZAHN USA SIGN A COOPERATION AGREEMENT FOR UNITED STATES AND CANADA Source text for Eikon: Further company coverage: (Gdynia Newsroom)

BRIEF-Straumann Holding Says Too Early To Change FY Outlook

* SAYS TOO EARLY TO CHANGE FY OUTLOOK - CONF CALL Further company coverage: (Gdynia Newsroom)

BRIEF-Straumann Holding Q1 Revenue Up 22 Pct At CHF 324 Million

* Q1 GROUP REVENUE CLIMBS 22% IN SWISS FRANCS TO CHF 324 MILLION

BRIEF-Straumann Holding Says Invests In Dental Monitoring

* INVESTS IN DENTAL MONITORING, A PIONEER IN REMOTE MONITORING ENABLED BY ARTIFICIAL INTELLIGENCE

Straumann's margin outlook takes shine off revenue surge

Dental implant maker Straumann <STMN.S> said on Thursday it aims for a third straight year of double digit growth in 2018 after reporting annual revenue of more than $1 billion (710.63 million pounds) for the first time.

Quote and financial data from Refinitiv. Fund performance data provided by Lipper. All quotes delayed a minimum of 15 minutes.

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up